Examining mechanisms of protein complex at a basic cell biological level
A new study highlighting the importance of a large protein complex called the exocyst in cell growth, division and communication reveals new functions and mechanisms that are essential to how molecules move across a membrane through vesicles in a cell.

Understanding how these mechanisms work in normal cells at the basic biological level will inform future research into how those functions are disrupted in developmental and neurological disorders.
“It’s the first time a role for membrane fusion has been described for this complex and it’s a breakthrough in how we think about the way the exocyst complex works,” said Mary Munson, professor and vice chair for diversity in the Department of Biochemistry & Molecular Biotechnology, associate vice provost for equity in science in the Office of Health Equity and a co-corresponding author on the study published in . The research was done in collaboration with Tae-Young Yoon, professor of biological sciences at the School of Biological Sciences and Institute for Molecular Biology and Genetics at Seoul National University in Seoul, South Korea.
“Until our collaborative study, exocyst was understood to recognize and possibly tether secretory vesicles to the cell membrane, prior to exocytosis. In this study, we reveal biophysical studies that indicate exocyst playing several critical roles that directly facilitate fusion of the vesicles with the cell membrane to drive cargo delivery,” Munson said.

Robust control of exocytosis is critical for all cells to grow, divide and communicate properly. Dysfunction of exocyst regulation has been linked to many physiological problems in different organisms.
“It’s really an exciting development in our field, as the exocyst complex had not previously been shown to directly control vesicle fusion,” Munson said. “The complex recognizes the right vessel, the right place on the cell surface and the right time for the cargo to be delivered. It does that by talking to the membrane fusion protein.”
In 2023, Munson received a for $3.3 million over five years to support this research.
Munson was recently named a of a Zenith Award from the Association for Women in Science. The award honors senior career professionals with a lifetime of innovative achievements in STEM and a commitment to workplace diversity.
This article is republished from the Read the original .
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ¾«Æ·¹ú²úÒ»Çø¶þÇøÌÒÉ« paper.